Four flawed arguments against prostate-specific antigen screening (and 1 good one)

Urology
Andrew Vickers

Abstract

Critics of prostate cancer screening have advanced several arguments as to why prostate-specific antigen (PSA) testing should be dramatically curtailed. In this personal reflection, I review 5 of these arguments, 4 of which are invalid. It is not true that the major randomized trial supporting prostate cancer screening, the European Randomized Study of Screening for Prostate Cancer, is flawed. Similarly, it is untrue that effects on prostate cancer mortality are only small, or that there are no effects at all on overall mortality. The fourth invalid argument is that PSA is a poor test and that it is impossible to tell whether screen-detected cancers are aggressive or indolent. But a fifth argument is indeed valid. PSA screening as it is currently practiced may not do more good than harm because of a high prevalence of screening of older men, gross overtreatment of low-risk disease, inadequate treatment of high-risk disease, and excessive rates of treatment at low-volume centers. The question for the urology community is whether it can be more restrictive about screening, biopsy, and treatment and more readily refer patients to higher volume institutions. Ultimately, the way to win the debate about PSA screening is not only to b...Continue Reading

References

Feb 7, 2002·Journal of the National Cancer Institute·William C BlackH Gilbert Welch
Mar 21, 2002·The Lancet Oncology·S D FossåUNKNOWN Norwegian Urological Cancer Group
Jun 6, 2002·Journal of the National Cancer Institute·Mitchell H Gail, Hormuzd A Katki
Apr 17, 2004·Archives of Pathology & Laboratory Medicine·Oluwole FadareM Rajan Mariappan
Mar 20, 2009·The New England Journal of Medicine·Michael J Barry
Mar 20, 2009·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators
Jun 6, 2009·Nature Reviews. Urology·Andrew J Vickers, Hans Lilja
Sep 10, 2009·International Journal of Cancer. Journal International Du Cancer·Tineke WoltersFritz H Schröder
Oct 20, 2009·The Journal of Urology·Caroline J Savage, Andrew J Vickers
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew R CooperbergPeter R Carroll
Apr 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew VickersHans Lilja
Sep 17, 2010·BMJ : British Medical Journal·Mia DjulbegovicPhilipp Dahm
Nov 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E David CrawfordAnthony V D'Amico
Mar 23, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter B Bach, Andrew J Vickers
Dec 29, 2011·JAMA : the Journal of the American Medical Association·Roger Chou, Michael L LeFevre
Jun 20, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sigrid CarlssonJonas Hugosson
Jul 18, 2012·Annals of Internal Medicine·Virginia A Moyer, UNKNOWN U.S. Preventive Services Task Force
Jul 20, 2012·The New England Journal of Medicine·Timothy J WiltUNKNOWN Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group
Aug 17, 2012·The New England Journal of Medicine·Eveline A M HeijnsdijkHarry J de Koning
Nov 13, 2012·The Journal of Urology·Patrick C Walsh
Mar 1, 2013·BJU International·Sigrid CarlssonJonas Hugosson

❮ Previous
Next ❯

Citations

Apr 30, 2017·Abdominal Radiology·Eric J JordanAntonio C Westphalen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Related Papers

Journal of Medical Screening
Obertová ZuzanaGilling Peter
JAMA : the Journal of the American Medical Association
Julia H Hayes, M J Barry
American Journal of Clinical and Experimental Urology
Christopher Sejong HanIsaac Yi Kim
The New England Journal of Medicine
Fritz H SchröderERSPC Investigators
© 2022 Meta ULC. All rights reserved